Investigating high levels of fibroblast TGFBI in pancreatic cancer tissues, Goehrig and colleagues found that this molecule interacted directly with T cells and macrophages and that neutralising anti-TGFBI antibodies reduced tumor growth, enhanced CD8+ T-cell activation, and polarized macrophages to an M1 state. Here, TGFBI is linked to pancreatic neoplasm.